Get Your FREE Picks for May 14 2024  Click here

Latest News

Cresco Labs, First Quarter 2019 Financial Results Revenue Growth: 313% Year-over-Year

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is one of the largest vertically integrated multistate cannabis operators in the United States.

Revenue

  • First quarter revenue of $21.1 million, up 313%
  • First quarter pro forma revenue1 of $33.9 million, which includes the impact of pending acquisitions in New York, Massachusetts, Florida, and in California with Origin House.

Net Income

  • First quarter net loss of $7.6 million, compared to net income of $0.6 million in the prior-year period.

Balance Sheet

  • As of fiscal year-end, total assets of $364.0 million, including cash and cash equivalents of $106.1 million and a working capital position of $146.3 million with zero debt on the balance sheet.

Operations

  • The Company is operational in seven U.S. states, with binding transactions pending in New York, Massachusetts and Florida, as well as approved expansion into Michigan.
  • On April 1, 2019, the Company announced that it has entered into a definitive agreement with CannaRoyalty Corp. (d/b/a Origin House), a premier cannabis brand distributor, which at the time was the largest-ever public company acquisition in the U.S. cannabis sector.

Talent

  • Continued hiring top talent through key appointments and acquisitions, total staff headcount to over 835 employees at the end of the first quarter of 2019.

Voluntary Shares Lock-up 97%

  • Shareholders representing 205,172,192 common shares have entered into voluntary lock-up agreements representing 97% of the shares subject to the initial lock-up and 80% of the total issued subordinate voting shares (on an as-if converted basis).

Editor, Daily Stock Deals

 

 

Top 10 E-Cig & Vaping Facts 

 

 

Editor’s note:

An Extremely Confidential and Highly Insightful Report, a must read for every Cannabis Company CEO ‘The Future of Cannabis in America’ and Canada Cannabis Inc.  Contact now!

You will learn: How JUUL’s problems, CDC, FDA crackdown and impending Federal/State regulations may affect the future of Cannabis Industry and how you can opportunistically navigate, stay complaint and thrive, while your competition withers away! 

 

Get Yours: Contact now!

Copyright©2017 Daily Stock Deals TM,

Today's Top 10 Stocks TM, All Rights Reserved Worldwide.

Daily Stock Deals is a division of Placebo Media Group

Get in Touch

Daily Stock Deals

A Sound View Plaza 1266 E Main St. 7th Floor, Stamford, CT 06902 USA

T 214 810 5549

Comodo SSL